Evaluation of preoperative hematologic markers as prognostic factors and establishment of novel risk stratification in resected pN0 non-small-cell lung cancer

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhang, Tiehong ^a   Jiang, Yuanzhu ^a   Qu, Xiao ^a   Shen, Hongchang ^a   Liu, Qi ^a   Du, Jiajun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; SURVIVAL PREDICTION; TUMOR VOLUME; VERY ELDERLY; BLOOD; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL; PATHOLOGY; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; THROMBOCYTE COUNT;

BIOLOGICAL MARKER;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUTROPHILS; PLATELET COUNT; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84909990258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111494     Document Type: Article

References (26)

1. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
2. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science Signaling 331: 1565.
3. Brenner DR, Boffetta P, Duell EJ, Bickeböller H, Rosenberger A, et al. (2012) Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. American journal of epidemiology 176: 573-585.
4. Gorczyca W (2011) Prognostic and predictive markers in hematologic neoplasms. A review. POL J PATHOL 4: 189-205.
5. Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T (2009) Preoperative leukocytosis, anemia and thrombocytosis are associated with poor survival in non-small cell lung cancer. Anticancer research 29: 2687-2690.
6. Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, et al. (2012) Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 79: 1085-1091.
7. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI (2010) Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. The American Journal of Surgery 200: 197-203.
8. Azab B, Shah N, Radbel J, Tan P, Bhatt V, et al. (2013) Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Medical Oncology 30: 1-11.
9. He W, Yin C, Guo G, Jiang C, Wang F, et al. (2013) Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Medical Oncology 30: 1-6.
10. Yao Y, Yuan D, Liu H, Gu X, Song Y (2013) Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunology, Immunotherapy: 1-9.
11. Cedrés S, Torrejon D, Martínez A, Martinez P, Navarro A, et al. (2012) Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clinical and Translational Oncology 14: 864-869.
12. Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, et al. (2009) Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. European Journal of Cancer 45: 1950-1958.
13. Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, et al. (2012) Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung cancer 75: 223-227.
14. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T (2012) Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. Journal of gynecologic oncology 23: 265-273.
15. Arrieta O, Ortega RM, Villanueva-Rodríguez G, Serna-Thomé M, Flores-Estrada D, et al. (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC cancer 10: 50.
16. Metz CE (1978) Basic principles of ROC analysis. Elsevier. 283-298.
17. Van der Schouw Y, Verbeek A, Ruijs J (1992) ROC curves for the initial assessment of new diagnostic tests. Family Practice 9: 506-511.
18. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, et al. (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery 137: 425-428.
19. Kim D, Kwak Y, Cho S (2012) 445. Associations Between White Blood Cell, Neutrophil, Lymphocyte Counts and Neutrophil/lymphocyte Ratio on Preoperative Blood Samples and Survival After Complete Resection for Non-small Cell Lung Cancer. European Journal of Surgical Oncology (EJSO) 38: 861-862.
20. Tomita M, Shimizu T, Ayabe T, Onitsuka T (2012) Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer research 32: 3535-3538.
21. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T (2011) Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer research 31: 2995-2998.
22. Asahi Y, Kubonishi I, Imamura J, Kamioka M, Matsushita H, et al. (1996) Establishment of a Clonal Cell Line Producing Granulocyte Colony-Stimulating Factor and Parathyroid Hormone-Related Protein from a Lung Cancer Patient with Leukocytosis and Hypercalcemia. Cancer Science 87: 451-458.
23. Alexandrakis M, Passam F, Perisinakis K, Ganotakis E, Margantinis G, et al. (2002) Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respiratory medicine 96: 553-558.
24. B Vendramini-Costa D, E Carvalho J (2012) Molecular link mechanisms between inflammation and cancer. Current pharmaceutical design 18: 3831-3852.
25. Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, et al. (2006) Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. British journal of cancer 94: 275-280.
26. Peterson JE, Zurakowski D, Italiano Jr JE, Michel LV, Connors S, et al. (2012) VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis 15: 265-273.